BamSEC and AlphaSense Join Forces
Learn More

Tenax Therapeutics Inc.

NASDAQ: TENX    
Share price (12/20/24): $5.61    
Market cap (12/20/24): $19.1 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.2
from 8-K 19 pages Form of Warrant to Purchase Shares of Common Stock or Pre-Funded Warrants
12/34/56
EX-4.1
from 8-K 17 pages Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.20
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.3
from 8-K 16 pages Common Stock Purchase Warrant Tenax Therapeutics, Inc
12/34/56
EX-4.2
from 8-K 17 pages Pre-Funded Common Stock Purchase Warrant Tenax Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 20 pages Tenax Therapeutics, Inc. and Direct Transfer LLC as Warrant Agent Warrant Agency Agreement Dated as of February 12, 2024 Warrant Agency Agreement
12/34/56
EX-4.22
from S-1/A 17 pages Pre-Funded Common Stock Purchase Warrant Tenax Therapeutics, Inc
12/34/56
EX-4.21
from S-1/A 16 pages Common Stock Purchase Warrant Tenax Therapeutics, Inc
12/34/56
EX-4.20
from S-1/A 21 pages Tenax Therapeutics, Inc. and Direct Transfer LLC as Warrant Agent Warrant Agency Agreement Dated as of [•], 2024 Warrant Agency Agreement
12/34/56
EX-4.17
from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.3
from 8-K 17 pages Common Stock Purchase Warrant Tenax Therapeutics, Inc
12/34/56
EX-4.2
from 8-K 18 pages Pre-Funded Common Stock Purchase Warrant Tenax Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 20 pages Tenax Therapeutics, Inc. and Direct Transfer LLC as Warrant Agent Warrant Agency Agreement Dated as of February 7, 2023 Warrant Agency Agreement
12/34/56
EX-4.19
from S-1/A 17 pages Pre-Funded Common Stock Purchase Warrant Tenax Therapeutics, Inc
12/34/56
EX-4.18
from S-1/A 16 pages Common Stock Purchase Warrant Tenax Therapeutics, Inc
12/34/56
EX-4.17
from S-1/A 21 pages Tenax Therapeutics, Inc. and Direct Transfer LLC as Warrant Agent Warrant Agency Agreement Dated as of [•], 2023 Warrant Agency Agreement
12/34/56
EX-4.3
from 8-K 3 pages Armistice Capital Master Fund Ltd. C/O Armistice Capital, LLC 510 Madison Avenue, 7th Floor New York, Ny 10022 Re: Amendments to Existing Warrants Held by Armistice Capital Master Fund Ltd. (The “Holder”) Dear Holder
12/34/56
EX-4.2
from 8-K 19 pages Series E Common Stock Purchase Warrant Tenax Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 19 pages Pre-Funded Common Stock Purchase Warrant Tenax Therapeutics, Inc
12/34/56
EX-4.14
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56